pandas is a Python module that's popular in data science and data analysis. It's offers a way to organize data into ...

North Korea’s Contagious Interview spreads AkdoorTea and TsunamiKit to steal crypto and infiltrate global developers.

The threat actor behind the malware-as-a-service (MaaS) framework and loader called CastleLoader has also developed a remote access trojan known as CastleRAT. "Available in both Python and C variants, ...

58 shot, 8 dead, in Chicago amid Trump's threat to deploy National Guard Donald Trump responds to object thrown out of White House window This hidden electricity drain can have a massive impact Josh ...

Experts caution that tolerance for cannabis may reduce its value as a long-term sleep aid, and note other health risks associated with chronic cannabis use. People with insomnia experienced improved ...

Binance Lists Donald Trump-Linked WLFI Token; to Be Traded on Three Blockchains Binance lists WLFI token with liquidity concerns as 70 percent insider control sparks debate on decentralisation.

Binance is the first crypto exchange to list World Liberty Financial (WLFI), the Trump-family-linked decentralized finance (DeFI) project, with trading set to begin Monday afternoon UTC time, ...

Turkey has introduced sweeping restrictions prohibiting ships linked to Israel from accessing its ports, in a move that further escalates Ankara’s measures against Tel Aviv amid the ongoing war in ...

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

WASHINGTON, Aug 5 (Reuters) - OpenAI's ChatGPT, Google's Gemini and Anthropic's Claude have been added to a list of approved AI vendors, the U.S. government's central purchasing arm said on Tuesday, ...

No difference in mortality risk was seen for GLP-1 RA and SGLT2i users; significantly lower risk was seen for GLP-1 RA vs DPP4i users. HealthDay News — For older patients with cancer and type 2 ...